Drugs.com - Pharma Industry News

Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment

TUESDAY, March 11, 2025 -- For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase inhibitor, remibrutinib, results...

Mar 11, 2025 - 18:23
 0
Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
TUESDAY, March 11, 2025 -- For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase inhibitor, remibrutinib, results...
Read More

Tags:

Previous Article

AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications

Next Article

Sleep Time in First Week Postconcussion Linked to Youth Recovery Outcomes

Related Posts

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Pr...

Feb 18, 2025  0

Boarding Common While Awaiting Acute Pediatric Psychiatric Care

Boarding Common While Awaiting Acute Pediatric Psychiat...

Feb 13, 2025  0

Recording of Nystagmus During Vertigo in Meniere Disease May Offer Therapeutic Aid

Recording of Nystagmus During Vertigo in Meniere Diseas...

Feb 9, 2025  0